look ahead to the next week in biotech:

Earnings season is approaching, which means once again, analysts will get the opportunity to punch “star-1” on their telephone keypads to ask the management team at Gilead Sciences, “Who are you going to buy?”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.